Carcinoembryonic antigen surge in metastatic colorectal cancer patients responding to irinotecan combination chemotherapy

By An Xin   Ding Pei-Rong   Xiang Xiao-Juan   Wang Zhi-Qiang   Wang Feng-Hua   Feng Fen   Jiang Wen-Qi   He You-Jian   Xu Rui-Hua   Li Yu-Hong  

Biomarkers, Vol. 15, Iss. 3, 2010-05 ,pp. : 243-248

Informa Healthcare

Access to resources Recommend Favorite

The clinical efficacy and safety of certolizumab pegol in rheumatoid arthritis

By Fleischmann Roy  

Expert Opinion on Biological Therapy, Vol. 10, Iss. 5, 2010-05 ,pp. : 773-786

Informa Healthcare

Access to resources Recommend Favorite

Antiangiogenesis therapy in second line metastatic colorectal cancer: similar but different

By Saif Muhammad Wasif  

Expert Opinion on Biological Therapy, Vol. 13, Iss. 11, 2013-11 ,pp. : 1489-1493

Informa Healthcare

Access to resources Recommend Favorite

Agalsidase alfa for the treatment of Fabry disease: new data on clinical efficacy and safety

By Beck Michael  

Expert Opinion on Biological Therapy, Vol. 9, Iss. 2, 2009-02 ,pp. : 255-261

Informa Healthcare

Access to resources Recommend Favorite

Cytotoxic triplets plus a biologic: state-of-the-art in maximizing the potential of up-front medical treatment of metastatic colorectal cancer

By Loupakis Fotios   Cremolini Chiara   Schirripa Marta   Masi Gianluca   Falcone Alfredo  

Expert Opinion on Biological Therapy, Vol. 11, Iss. 4, 2011-04 ,pp. : 519-531

Informa Healthcare

Access to resources Recommend Favorite